Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page
- Check6 days agoChange DetectedRecruitment status changed to 'No longer looking for participants'. The page adds new guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updates the Intervention/Treatment label, along with a revision to v3.6.0.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page revision level was updated from v3.5.4 to v3.5.5, indicating a small internal update to the page metadata.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3. This reflects a technical site update and does not modify the study content or displayed results.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a minor administrative update to the study record.SummaryDifference0.1%

- Check63 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.5.0 was added; Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.